Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Reviva Pharmaceuticals I...

    NASDAQ: RVPH · Real-Time Price · USD
    0.35
    -0.41 (-54.17%)
    At close: Jun 26, 2025, 3:59 PM

    Reviva Pharmaceuticals Statistics

    Share Statistics

    Reviva Pharmaceuticals has 46.74M shares outstanding. The number of shares has increased by 56.22% in one year.

    Shares Outstanding

    n/a
    		 46.74M

    Shares Change (YoY)

    n/a
    		 56.22%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 22.87%

    Shares Floating

    n/a
    		 41.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 990

    FTD / Avg. Volume

    n/a
    		 0.15%

    Short Selling Information

    The latest short interest is 3.28M, so 7.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.28M

    Short % of Shares Out

    n/a
    		 7.01%

    Short % of Float

    n/a
    		 8.12%

    Short Ratio (days to cover)

    n/a
    		 5.06

    Valuation Ratios

    The PE ratio is -2.01 and the forward PE ratio is -1.23. Reviva Pharmaceuticals's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -2.01

    Forward PE

    n/a
    		 -1.23

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 73.84

    P/FCF Ratio

    n/a
    		 -1.79

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Reviva Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.56.

    Current Ratio

    n/a
    		 1.01

    Quick Ratio

    n/a
    		 1.01

    Debt / Equity

    n/a
    		 0.56

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -1665.07

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,137,057.29

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 19.51K

    Effective Tax Rate

    n/a
    		 -0.07%

    Stock Price Statistics

    The stock price has increased by -39.2% in the last 52 weeks. The beta is 0.11, so Reviva Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.11

    52-Week Price Change

    n/a
    		 -39.2%

    50-Day Moving Average

    n/a
    		 0.84

    200-Day Moving Average

    n/a
    		 1.26

    Relative Strength Index (RSI)

    n/a
    		 46.17

    Average Volume (20 Days)

    n/a
    		 677,951

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -30.8M

    Net Income

    n/a
    		 -29.92M

    EBITDA

    n/a
    		 -29.88M

    EBIT

    n/a
    		 -29.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.9
    Full Income Statement

    Balance Sheet

    The company has 13.48M in cash and 458.15K in debt, giving a net cash position of 13.02M.

    Cash & Cash Equivalents

    n/a
    		 13.48M

    Total Debt

    n/a
    		 458.15K

    Net Cash

    n/a
    		 13.02M

    Retained Earnings

    n/a
    		 -164.27M

    Total Assets

    n/a
    		 15.5M

    Working Capital

    n/a
    		 81.86K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -33.54M and capital expenditures 0, giving a free cash flow of -33.54M.

    Operating Cash Flow

    n/a
    		 -33.54M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -33.54M

    FCF Per Share

    n/a
    		 -1.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RVPH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RVPH is $9, which is 1084.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 1084.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -17.87

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist